Benzinga | Dec 15, 2021 04:08PM EST

Enzo Biochem Q1 EPS $(0.05) Down From $0.01 YoY, Sales $26.50M Down From $28.66M YoY

Enzo Biochem (NYSE:ENZ) reported quarterly losses of $(0.05) per share. This is a 600 percent decrease over earnings of $0.01 per share from the same period last year. The company reported $26.50 million in sales this quarter. This is a 7.52 percent decrease over sales of $28.66 million the same period last year.